Kyverna Therapeutics Inc. (KYTX), which debuted on the Nasdaq as recently as February of this year, has since lost more than 20% of its stock value. The company's lead program is KYV-101, an autologous CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) product candidate for use in B cell-driven autoimmune diseases such as lupus nephritis, systemic sclerosis, and inflammatory myopathies. KYV-101 is...
For comments and feedback contact: editorial@rttnews.com
May 08, 2026 15:50 ET Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.